Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honghe Wan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Organic Chemistry|July 20, 2002
Chiral nonracemic alpha-alkylidene and alpha-silylidene cyclopentenones from chiral allenes using an intramolecular allenic Pauson-Khand-type cycloadditionKay M Brummond, Angela D Kerekes, Honghe Wan
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Identification of a potent and rapidly reversible inhibitor of the 20S-proteasomeAshok V Purandare, Honghe Wan, Naomi Laing, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Identification of chemokine receptor CCR4 antagonistAshok V Purandare, Aiming Gao, Honghe Wan, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
Core exploration in optimization of chemokine receptor CCR4 antagonistsAshok V Purandare, Honghe Wan, John E Somerville, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2005
Optimization of CCR4 antagonists: side-chain explorationAshok V Purandare, Honghe Wan, Aiming Gao, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studiesHonghe Wan, Tram Huynh, Suhong Pang, et al.
Journal of Medicinal Chemistry|October 27, 2021
Long-Acting Tumor-Activated Prodrug of a TGFβR InhibitorYong Zhang, Karen E Parrish, David R Tortolani, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)Christopher P Mussari, Dharmpal S Dodd, Ratna Kumar Sreekantha, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine InhibitorsAmy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2021
Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonistsZheming Ruan, Peter K Park, Donna Wei, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Organic Chemistry|July 20, 2002
Chiral nonracemic alpha-alkylidene and alpha-silylidene cyclopentenones from chiral allenes using an intramolecular allenic Pauson-Khand-type cycloadditionKay M Brummond, Angela D Kerekes, Honghe Wan
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Identification of a potent and rapidly reversible inhibitor of the 20S-proteasomeAshok V Purandare, Honghe Wan, Naomi Laing, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Identification of chemokine receptor CCR4 antagonistAshok V Purandare, Aiming Gao, Honghe Wan, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
Core exploration in optimization of chemokine receptor CCR4 antagonistsAshok V Purandare, Honghe Wan, John E Somerville, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2005
Optimization of CCR4 antagonists: side-chain explorationAshok V Purandare, Honghe Wan, Aiming Gao, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studiesHonghe Wan, Tram Huynh, Suhong Pang, et al.
Journal of Medicinal Chemistry|October 27, 2021
Long-Acting Tumor-Activated Prodrug of a TGFβR InhibitorYong Zhang, Karen E Parrish, David R Tortolani, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)Christopher P Mussari, Dharmpal S Dodd, Ratna Kumar Sreekantha, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine InhibitorsAmy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2021
Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonistsZheming Ruan, Peter K Park, Donna Wei, et al.
Pageof 2